No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 135,553 | 221,036 | 178,414 | 174,543 | 198,381 | 204,590 | N/A | N/A |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 5,036 | 25,961 | 7,541 | 2,547 | 5,323 | 5,857 | N/A | N/A |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
BOE Technology Group Company Limited, established in Beijing, China in 1993, operates as a global Internet of Things (IoT) company. It is dedicated to delivering advanced intelligent interface products and expert services that facilitate information interaction and promote human well-being across the world. The company's operations are organized into several strategic business units. Its Display Business focuses on cutting-edge screen technologies, including TFT-LCD, AMOLED Oxide, and Microdisplay. These technologies are integrated into an extensive array of devices such as smartphones, tablets, laptops, computer monitors, televisions, in-vehicle displays, electronic shelf labels, tiled display screens, industrial control systems, wearables, VR/AR devices, electronic tags, home appliances, healthcare equipment, mobile payment solutions, and interactive whiteboards. This segment also offers various smart terminal products, such as low-power and 3D displays, alongside comprehensive design and manufacturing services for system solutions. Through its IoT Innovation Business, BOE provides integrated hardware and software solutions tailored for smart finance, intelligent parks, government affairs, transportation, and energy sectors. It also offers urban light space services and large-scale product solutions. The Sensor and Application Solutions segment is committed to the design and production of sophisticated sensor devices and system solutions. These cater to diverse applications in medical biological detection, transportation, construction, consumer electronics, microwave communications, and industrial sensing, featuring products like flat panel X-ray detectors, digital microfluidic chips, PDLC glass, fingerprint identification systems, and industrial sensors. Additionally, BOE is a prominent provider of Mini LED backlight and display products. Its Smart Medicine & Engineering division delivers a full spectrum of healthcare services, encompassing digital hospital management, health management powered by an IoT platform, and a complete continuum of care from prevention, treatment, and therapy to nursing, complemented by associated technology services.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
BOE Technology Group Company Limited (000725.SZ)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
BOE Technology Group Company Limited, established in Beijing, China in 1993, operates as a global Internet of Things (IoT) company. It is dedicated to delivering advanced intelligent interface products and expert services that facilitate information interaction and promote human well-being across the world. The company's operations are organized into several strategic business units. Its Display Business focuses on cutting-edge screen technologies, including TFT-LCD, AMOLED Oxide, and Microdisplay. These technologies are integrated into an extensive array of devices such as smartphones, tablets, laptops, computer monitors, televisions, in-vehicle displays, electronic shelf labels, tiled display screens, industrial control systems, wearables, VR/AR devices, electronic tags, home appliances, healthcare equipment, mobile payment solutions, and interactive whiteboards. This segment also offers various smart terminal products, such as low-power and 3D displays, alongside comprehensive design and manufacturing services for system solutions. Through its IoT Innovation Business, BOE provides integrated hardware and software solutions tailored for smart finance, intelligent parks, government affairs, transportation, and energy sectors. It also offers urban light space services and large-scale product solutions. The Sensor and Application Solutions segment is committed to the design and production of sophisticated sensor devices and system solutions. These cater to diverse applications in medical biological detection, transportation, construction, consumer electronics, microwave communications, and industrial sensing, featuring products like flat panel X-ray detectors, digital microfluidic chips, PDLC glass, fingerprint identification systems, and industrial sensors. Additionally, BOE is a prominent provider of Mini LED backlight and display products. Its Smart Medicine & Engineering division delivers a full spectrum of healthcare services, encompassing digital hospital management, health management powered by an IoT platform, and a complete continuum of care from prevention, treatment, and therapy to nursing, complemented by associated technology services.